ATE120799T1 - Mutein von hst-1 und seine herstellung. - Google Patents

Mutein von hst-1 und seine herstellung.

Info

Publication number: ATE120799T1
Authority: AT; Austria
Prior art keywords: mutein; hst; production; wounds; heparin
Prior art date: 1989-10-06

Application number

AT90119127T

Other languages

English (en)

Inventor

Masaaki Terada

Hiromi Sakamoto

Teruhiko Yoshida

Koichi Igarashi

Yoshio Kozai

Original Assignee

Takeda Chemical Industries Ltd

President Of National Cancer C

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-10-06

Filing date

1990-10-05

Publication date

1995-04-15

1990-10-05 Application filed by Takeda Chemical Industries Ltd, President Of National Cancer C filed Critical Takeda Chemical Industries Ltd

1995-04-15 Application granted granted Critical

1995-04-15 Publication of ATE120799T1 publication Critical patent/ATE120799T1/de

Links

102100028072 Fibroblast growth factor 4 Human genes 0.000 title 1
101001060274 Homo sapiens Fibroblast growth factor 4 Proteins 0.000 title 1
101000993347 Gallus gallus Ciliary neurotrophic factor Proteins 0.000 abstract 1
101150101014 HST1 gene Proteins 0.000 abstract 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
208000032984 Intraoperative Complications Diseases 0.000 abstract 1
206010052428 Wound Diseases 0.000 abstract 1
208000027418 Wounds and injury Diseases 0.000 abstract 1
230000010261 cell growth Effects 0.000 abstract 1
230000037430 deletion Effects 0.000 abstract 1
238000012217 deletion Methods 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000035876 healing Effects 0.000 abstract 1
229960002897 heparin Drugs 0.000 abstract 1
229920000669 heparin Polymers 0.000 abstract 1
230000003248 secreting effect Effects 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1
230000001131 transforming effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Zoology (AREA)
Oncology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Transducers For Ultrasonic Waves (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT90119127T 1989-10-06 1990-10-05 Mutein von hst-1 und seine herstellung. ATE120799T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP26233189		1989-10-06
JP27303689		1989-10-19
JP30360789		1989-11-21

Publications (1)

Publication Number	Publication Date
ATE120799T1 true ATE120799T1 (de)	1995-04-15

Family

ID=27335120

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90119127T ATE120799T1 (de)	1989-10-06	1990-10-05	Mutein von hst-1 und seine herstellung.

Country Status (5)

Country	Link
US (1)	US5639862A (de)
EP (1)	EP0421455B1 (de)
AT (1)	ATE120799T1 (de)
CA (1)	CA2027075C (de)
DE (1)	DE69018357T2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5459250A (en) *	1987-06-16	1995-10-17	New York University	Truncated mammalian growth factor DNA sequence
ATE139700T1 (de) *	1991-02-15	1996-07-15	Takeda Chemical Industries Ltd	Mit einem zellwachstumsfaktor bewirkte anregung von wachstum im knocheninneren
EP0585631A1 (de) *	1992-08-05	1994-03-09	Takeda Chemical Industries, Ltd.	Blutplättchen vermehrendes Agens
EP0613946B1 (de) *	1993-02-12	2003-05-28	Takeda Chemical Industries, Ltd.	HST-2 Mutein, dafür kodierende DNS und Herstellung
AU760664B2 (en) *	1998-04-17	2003-05-22	Angiogenix, Inc.	Therapeutic angiogenic factors and methods for their use
US6451303B1 (en) *	1998-10-13	2002-09-17	Chiron Corporation	Method of treating coronary artery disease by administering a recombinant FGF

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0326907A1 (de) *	1988-01-26	1989-08-09	Takeda Chemical Industries, Ltd.	Polypeptide, DNA und ihre Verwendung

1990
- 1990-10-05 AT AT90119127T patent/ATE120799T1/de not_active IP Right Cessation
- 1990-10-05 EP EP90119127A patent/EP0421455B1/de not_active Expired - Lifetime
- 1990-10-05 CA CA002027075A patent/CA2027075C/en not_active Expired - Fee Related
- 1990-10-05 DE DE69018357T patent/DE69018357T2/de not_active Expired - Fee Related
1995
- 1995-05-19 US US08/446,198 patent/US5639862A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69018357T2 (de)	1995-09-21
CA2027075C (en)	2002-11-26
DE69018357D1 (de)	1995-05-11
EP0421455B1 (de)	1995-04-05
US5639862A (en)	1997-06-17
CA2027075A1 (en)	1991-04-07
EP0421455A1 (de)	1991-04-10

Similar Documents

Publication	Publication Date	Title
NO880719D0 (no)	1988-02-18	Polypeptid, dna og fremgangsmaate for fremstilling derav.
DE3674906D1 (de)	1990-11-15	Selbstklemmende medizinische prothese und ihre herstellung.
NO905264D0 (no)	1990-12-05	Fremgangsmaate for fremstilling av biologisk aktivt protein
ATE143811T1 (de)	1996-10-15	Herstellung und verwendung von il-6
EP0190018A3 (en)	1988-01-27	Use of transforming growth factor to promote wound healing and composition therefor
ATE79545T1 (de)	1992-09-15	Verwendung vom ''cartilage-inducing faktor b(cif- b)'' zur herstellung eines arzneimittels gegen das wachstum von tumoren.
DE68918331D1 (de)	1994-10-27	Menschlicher kristallinischer Granulocyt-Koloniestimulierungsfaktor und dessen Herstellung.
ATE97813T1 (de)	1993-12-15	Mittel zur kontrolle von thrombenbildungen.
DE69018357D1 (de)	1995-05-11	Mutein von HST-1 und seine Herstellung.
ATE189393T1 (de)	2000-02-15	Therapeutisches agens zur wundbehandlung
DE3781054D1 (de)	1992-09-17	Die verwendung von d-fenfluramin zur herstellung von arzneimitteln, zur behandlung von depressionen.
CA2011008A1 (en)	1990-09-01	Egf variants and pharmaceutical use thereof
DE68909254D1 (de)	1993-10-28	Heparinbindende Gehirnmitogene.
ATE117724T1 (de)	1995-02-15	Antibiotikum ge 22270, faktoren a1,a2,a3 und h.
SE8802805L (sv)	1989-02-05	Farmaceutisk komposition foer att underlaetta saarlaekning och foerfarande foer framstaellning av densamma
ES2094757T3 (es)	1997-02-01	Un factor megacariocitopoyetico.
NO873934L (no)	1988-03-23	Saarhelende serotoninantagonistisk forbindelse.
ATE86105T1 (de)	1993-03-15	Verwendung von probucol zur herstellung eines arzneimittels fuer die behandlung von herzarrhythmie.
ATE173921T1 (de)	1998-12-15	Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
ATE84418T1 (de)	1993-01-15	2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
UA8421A1 (uk)	1996-06-28	Препарат для лікування опіків, трофічних язв та раневих пошкоджень шкіри віватон-2
PT86174A (de)	1987-12-01	Homogenes schaft-tiits als zwischenprodukt zur herstellung von menschlichem tiits und dessen verwendung

Legal Events

Date	Code	Title	Description
1995-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties